Latent autoimmune diabetes of adults (LADA) manifested after the age of 35 is characterized by the presence of disease-specific autoantibodies (anti-glutamate decarboxylase GADAb, anti-IA2Ab). However, autoimmunity in Type 1 diabetes mellitus is not targeted only to pancreatic beta-cells. No data have so far been published concerning the antibodies associated with other autoimmune disease in LADA patients. The presence of anti-thyroglobulin (TGAb), anti-thyroid peroxidase (TPOAb), anti-gliadin IgA (AGAAb) and IgG (AGGAb) and endomysial antibodies (EMAb) in sera of 68 diabetics typed as LADA was compared with the antibody presence in sera of 85 patients with Type 2 diabetes. We found a significantly higher occurrence of gliadin antibodies in LADA patients: the rate of AGGAb was 19.1% in comparison with 3.5% in the T2DM group (P = 0.0026), the rate of AGAAb was 13.2% in comparison with 3.5% (P = 0.035). The prevalence of EMAb was very low in both groups (1.5% and 0). The two groups differed significantly in the TPOAb rate: 22.1% in LADA compared to 9.4% in T2DM (P = 0.04), whereas no significant difference was found in the presence of TGAb (8.8% and 3.5%, P = 0.187). In comparison with T2DM patients, LADA patients were found to express higher antibody activity against gluten-related antigens and against TPO.

Department of Cell and Molecular Immunology 3rd Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Wucherpfennig KW, Eisenbarth GS. Type 1 diabetes. Nat Immunol. 2001;9:767–8. PubMed

Lohman T, Kellner K, Verlohren HL, et al. Titer and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adult (LADA) Diabetologia. 2001;44:1005–10. PubMed

Esteban LM, Baxter AG. Polyspecificity of autoimmune responses in Type 1 (autoimmune) diabetes. Clin Exp Immunol. 2001;126:184–6. PubMed PMC

Sigurs N, Johansson C, Elfstrand PO, et al. Prevalence of coeliac disease in diabetic children and adolescents in Sweden. Acta Paediatr. 1993;82:748–51. PubMed

Ascher H, Hahn-Zoric M, Hanson LA, Kilander AF, Nilsson LA, Tlaskalova H. Value of serologic markers for clinical diagnosis and population studies of coeliac disease. Scand J Gastroenterol. 1996;31:61–7. PubMed

Tučková L, Karská K, Walters JRF, et al. Anti-gliadin antibodies in patients with coeliac disease cross-react with enterocytes and human calreticulin. Clin Immunol Immunopathol. 1997;85:289–96. PubMed

Cataldo F, Ventura A, Lazzar R, et al. Antiendomysium antibodies and coeliac disease: solved and unsolved question. An Italian multicenter study. Acta Paediatr. 1995;84:1125–31. PubMed

Calero P, Ribes-Koninck C, Albiach V, et al. IgA anti-gliadin antibodies as a screening method for nonovert coeliac disease in children with insulin-dependent diabetes mellitus. J Pediatr Gastroenterol Nutr. 1996;23:29–33. PubMed

Fernandez-Castaner M, Molina A, Lopez-Jimenez L, et al. Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity. Diabetes Care. 1999;22:377–81. PubMed

Weetman AP. Determinants of autoimmune thyroid disease. Nat Immunol. 2001;2:769–70. PubMed

Gambelunghe G, Forini F, Laureti S, et al. Increased risk for endocrine autoimmunity in Italian Type 2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol. 2000;52:565–73. PubMed

De Block CE, de Leeuw IH, Vertommen JJ, et al. Beta-cell, thyroid, gastric adrenal and coeliac autoimmunity and HLA-DQ types in Type 1 diabetes. Clin Exp Immunol. 2001;126:236–41. PubMed PMC

Silverberg AB, Mooradian AD. The thyroid and aging. In: Mobbs CV, Hof PR, editors. Functional endocrinology of aging. Basel: Karger; 1998. pp. 27–43.

Kaufman DL, Clare-Salzer M, Tian J, et al. Spontaneous loss of T cell tolerance to GAD in murine insulin dependents diabetes. Nature. 1993;366:69–72. PubMed PMC

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2001;24(Suppl.):S5–S20. PubMed

Not T, Citta A, Lucchesi A, et al. Anti-endomysium antibody on human umbilical cord vein tissue: an inexpensive and sensitive diagnostic tool for the screening of coeliac disease. Eur J Pediatr. 1997;156:616–8. PubMed

Lorini R, Scotta MS, Avanzini M, et al. IgA antibodies to gliadin, reticulin and reticulin for coeliac disease screening in children with insulin-dependent diabetes mellitus. J Pediatr. 1994;124:994–6. PubMed

Verge CF, Howard NJ, Rowley MJ, et al. Anti-glutamate decarboxylase and her antibodies at the onset of childhood IDDM, a population based study. Diabetologia. 1994;37:1113–20. PubMed

Martin-Villsa JM, Lopez Suarez JC, Perez Blas M, et al. Coeliac- and entheropathy-associated autoantibodies in Spanish insulin-dependent diabetes mellitus patients and their relation to HLA antigens. J Diabetes Compl. 2001;15:38–43. PubMed

Schaber E, Granditsch G. IDDM and coeliac disease. Diabetes Care. 1994;17:1549–55. PubMed

Kapuscinska A, Zalewski T, Chorzelski TP. Disease specificity and dynamics of changes in IgA class anti-endomysial antibodies in coeliac diseases. J Pediatr Gastroenterol Nutr. 1987;6:529–34. PubMed

Ashabani A, Abushofa A, Abusrewill S, Abdelazez M, Tučková L, Tlaskalová-Hogenová H. The prevalence of coeliac disease in Libyan children with insulin-dependent diabetes mellitus. Diabetes/Metab Res Rev. 2003;19:69–75. PubMed

Gillet PNM, Gilletz HR, Israel DM, et al. High prevalence of coeliac disease in patients with Type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase. Can J Gastroenterol. 2000;5:297–301. PubMed

Cavell B, Stenhammar L, Ascher H, et al. Increasing incidence of childhood coeliac diseases in Sweden: results of a national study. Acta Pediatr. 1992;81:589–92. PubMed

Vančíková Z, Chlumecký V, Sokol D, et al. The serologic screening for coeliac disease in the general population (blood donors) and in some high-risk groups of adults (patients with autoimmune diseases, osteoporosis and infertility) in the Czech Republic − preliminary report. Folia Microbiol. 2002;47:753–8. PubMed

Kolb H, Pozzilli P. Cow's milk and type 1 diabetes: the gut immune system deserves attention. Immunol Today. 1999;20:108–10. PubMed

Harrison LC, Honeyman MC. Cow's milk and Type 1 diabetes. The real debate is about mucosal immune function. Diabetes. 1999;48:1501–7. PubMed

Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today. 1997;18:335–43. PubMed

Funda DP, Kaas A, Bock T, Tlaskalová-Hogenová H, Buschard K. Gluten-free diet prevents diabetes in NOD mice. Diabetes/Metab Res Rev. 1999;15:323–7. PubMed

Paronen J, Klemetti P, Kantele JM, et al. Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor a4b-integrin. Diabetes. 1977;46:583–8. PubMed

Hanninen A, Salmi M, Simell O, et al. Mucosa-associated (beta7-integrin high) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes. 1996;45:1173–80. PubMed

Savilahti E, Ormala T, Sukkonen T, et al. Jejuna of patients with insulin-dependent diabetes mellitus show signs of immune activation. Clin Exp Immunol. 1999;116:70–7. PubMed PMC

De Block CE, de Leeuw IH, van Gaal L, et al. High prevalence of manifestation of gastric autoimmunity in parietal cell antibody-positive Type 1 (insulin dependent) diabetic patients. J Clin Endocrinol Metab. 1999;84:4062–7. PubMed

The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases